Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456973 · ClinicalTrials.gov registry record · NA
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03456973 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT03456973, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The investigators propose to build and test a supportive care software platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) to be provided to metastatic breast cancer patients on Android Tablets. This program will be tested in 50 metastatic breast cancer patients within the Penn State Cancer Institute's 28 county catchment area. The company with whom the investigator will partner to develop this application is already working with multiple investigators at the institution (Webster Group).
Interventions
- BEHAVIORAL Nurse AMIE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03456973
The ClinicalTrials.gov registry entry for NCT03456973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nurse AMIE is the first listed.
NCT03456973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03456973 about?
NCT03456973 is a clinical study titled "Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer". The investigators propose to build and test a supportive care software platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) to be provided to metastatic breast cancer patients on Android Tablets. This program will be tested in 50 metastatic breast cancer patients within the Penn S...
What is the current status of trial NCT03456973?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-10-01. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT03456973?
The interventions under investigation include: Nurse AMIE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03456973?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.